Cargando…
Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
BACKGROUND AND OBJECTIVES: Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible, invariably fatal fibrotic lung disease with no lasting option for therapy. Mesenchymal stem cells (MSCs) could be a promising modality for the treatment of IPF. Aim of the study was to investigate improvem...
Autores principales: | Reddy, Manoj, Fonseca, Lyle, Gowda, Shashank, Chougule, Basavraj, Hari, Aarya, Totey, Satish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155715/ https://www.ncbi.nlm.nih.gov/pubmed/27871152 http://dx.doi.org/10.15283/ijsc16041 |
Ejemplares similares
-
Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin
por: Demirkol, Barış, et al.
Publicado: (2023) -
Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium
por: Liu, Yuan, et al.
Publicado: (2017) -
Pirfenidone suppresses bleomycin-induced pulmonary fibrosis and periostin expression in rats
por: Song, Xiaoxia, et al.
Publicado: (2018) -
Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2014) -
No effect of pirfenidone treatment in fulminant bleomycin-induced pneumonitis
por: Bendstrup, Elisabeth, et al.
Publicado: (2014)